SERIOUS INFECTION ACROSS BIOLOGIC TREATED PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM A NATIONAL REGISTRY

被引:0
|
作者
Rutherford, A. I. [1 ]
Subesinghe, S. [1 ]
Byng-Maddick, R. [2 ]
Hyrich, K. [3 ]
Galloway, J. B. [1 ]
机构
[1] Kings Coll London, Acad Rheumatol Dept, London, England
[2] Homerton Hosp, Rheumatol, London, England
[3] Univ Manchester, Arthrit Res UK Ctr Epidemiol, Manchester, Lancs, England
关键词
D O I
10.1136/annrheumdis-2017-eular.1711
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI0695
引用
收藏
页码:753 / 753
页数:1
相关论文
共 50 条
  • [21] Infections in patients with rheumatoid arthritis treated with biologic agents
    Listing, J
    Strangfeld, A
    Kary, S
    Rau, R
    von Hinueber, U
    Stoyanova-Scholz, M
    Gromnica-Ihle, E
    Antoni, C
    Herzer, P
    Kekow, J
    Schneider, M
    Zink, A
    ARTHRITIS AND RHEUMATISM, 2005, 52 (11): : 3403 - 3412
  • [22] Frailty Is Associated with Serious Infections in Biologic and Targeted-synthetic DMARD Treated Patients with Rheumatoid Arthritis
    Singh, Namrata
    Gold, Laura
    Wysham, Katherine
    Andrews, James
    Reid, Pankti
    Makris, Una
    England, Bryant
    Lee, Jiha
    George, Michael
    Baker, Joshua
    Jarvik, Jeffrey
    Heagerty, Patrick
    Singh, Siddharth
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4404 - 4406
  • [23] Frailty is associated with serious infections in biologic and targeted-synthetic DMARD treated patients with rheumatoid arthritis
    Singh, N.
    Gold, L.
    Lee, J.
    Wysham, K. D.
    Makris, U.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S156 - S156
  • [24] Characterizing Infusion-Related Reactions in Patients with Rheumatoid Arthritis Treated with Biologic DMARDs: Observations from the KOBIO Registry
    Kim, Ji-Won
    Jung, Ju-Yang
    Suh, Chang-Hee
    Kim, Hyoun-Ah
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1050 - 1052
  • [25] Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis
    Richter, A.
    Listing, J.
    Schneider, M.
    Klopsch, T.
    Kapelle, A.
    Kaufmann, J.
    Zink, A.
    Strangfeld, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (09) : 1667 - 1673
  • [26] Risk of Infections in Juvenile Idiopathic Arthritis Patients Treated with Biologic Agentsand/or Methotrexate: Results from Pharmachild Registry
    Giancane, Gabriella
    Swart, Joost
    Bovis, Francesca
    Castagnola, Elio
    Groll, Andreas
    Horneff, Gerd
    Huppertz, Hans-Iko
    Lovell, Daniel J.
    Wolfs, Tom
    Hofer, Michael
    Alexeeva, Ekaterina
    Panaviene, Violeta Vladislava
    Nielsen, Susan
    Anton, Jordi
    Uettwiller, Florence
    Stanevicha, Valda
    Trachana, Maria
    Marafon, Denise Pires
    Ailioaie, Constantin
    Tsitsami, Elena
    Kamphuis, Sylvia S. M.
    Herlin, Troels
    Dolezalova, Pavla
    Susic, Gordana
    Flato, Berit
    Sztajnbok, Flavio
    Pistorio, Angela
    Martini, Alberto
    Wulffraat, Nico
    Ruperto, Nicolino
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [27] THE RISK FACTORS OF SERIOUS INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hasegawa, E.
    Kobayashi, D.
    Ito, S.
    Narita, I.
    Nakazono, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1061 - 1061
  • [28] HOW HAS THE RISK OF SERIOUS INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH NON-BIOLOGIC DISEASE MODIFYING DRUGS CHANGED OVER TIME?
    Arkema, E.
    Askling, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 442 - 443
  • [29] Predictive Risk Factors of Serious Infections in RA Patients Treated with Abatacept in Real Life: Results in the Orencia and Rheumatoid Arthritis (ORA) Registry
    Gottenberg, Jacques-Eric
    Ravaud, Philippe
    Cantagrel, Alain G.
    Combe, Bernard
    Flipo, Rene-Marc
    Schaeverbeke, Thierry
    Houvenagel, Eric
    Gaudin, Philippe
    Loeuille, Damien
    Rist, Stephanie
    Dougados, Maxime
    Sibilia, Jean
    Le Loet, Xavier
    Marcelli, Christian
    Bardin, Thomas
    Pane, Isabelle
    Perrodeau, Elodie
    Baron, Gabriel
    Mariette, Xavier
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S562 - S562
  • [30] Risk of Hospitalized Infection Among Rheumatoid Arthritis Patients Concurrently Treated With a Biologic Agent and Denosumab
    Curtis, Jeffrey R.
    Xie, Fenglong
    Yun, Huifeng
    Saag, Kenneth G.
    Chen, Lang
    Delzell, Elizabeth
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (06) : 1456 - 1464